US 12,220,166 B2
Target identification with optical feedback signal splitter
Sergey A. Bukesov, Acton, MA (US); Kurt G. Shelton, Bedford, MA (US); and Brian M. Talbot, Southborough, MA (US)
Assigned to Gyrus ACMI, Inc., Westborough, MA (US)
Filed by GYRUS ACMI, INC., Westborough, MA (US)
Filed on Jun. 9, 2023, as Appl. No. 18/332,072.
Application 18/332,072 is a continuation of application No. 18/055,486, filed on Nov. 15, 2022.
Application 18/055,486 is a continuation of application No. 16/984,447, filed on Aug. 4, 2020, granted, now 11,523,865.
Claims priority of provisional application 63/018,262, filed on Apr. 30, 2020.
Claims priority of provisional application 63/008,940, filed on Apr. 13, 2020.
Claims priority of provisional application 62/931,360, filed on Nov. 6, 2019.
Claims priority of provisional application 62/882,837, filed on Aug. 5, 2019.
Prior Publication US 2023/0310076 A1, Oct. 5, 2023
Int. Cl. A61B 18/18 (2006.01); G02B 27/12 (2006.01); G02B 27/14 (2006.01); H04B 10/25 (2013.01); H04B 10/50 (2013.01); H04B 10/60 (2013.01); A61B 18/00 (2006.01); A61B 18/20 (2006.01); A61B 18/22 (2006.01); A61B 18/26 (2006.01)
CPC A61B 18/18 (2013.01) [G02B 27/123 (2013.01); G02B 27/141 (2013.01); H04B 10/25 (2013.01); H04B 10/503 (2013.01); H04B 10/60 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00982 (2013.01); A61B 2018/20355 (2017.05); A61B 2018/20361 (2017.05); A61B 2018/2205 (2013.01); A61B 2018/2261 (2013.01); A61B 2018/2266 (2013.01); A61B 2018/2277 (2013.01); A61B 18/26 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of providing therapeutic treatment of an anatomical target, the method comprising:
(a) delivering a light beam, generated by a light source, to the anatomical target via a first optical path in a probe;
(b) in response to the delivery of the light beam to the anatomical target, collecting an optical response signal from the anatomical target and passing the optical response signal through a second optical path, at least a portion of the second optical path being defined by a beam splitter and the portion of the second optical path that is defined by the beam splitter being different from the first optical path;
(c) redirecting at least a portion of the optical response signal to an optical detection system;
(d) based at least in part on the redirected at least a portion of the optical response signal, identifying a characteristic of the anatomical target; and
(e) controlling an energy source to deliver a therapeutic beam, different from the light beam, to treat the anatomical target in accordance with the identified characteristic of the anatomical target.